Systematic benchmarking shows existing transcriptomic predictors for immune checkpoint inhibitor response have limited cross-cohort generalisability and inconsistent biomarker signals.
Granzyme family acts as a predict biomarker in cutaneous melanoma and indicates more benefit from anti-PD-1 immunotherapy
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
citation-role summary
background 1
citation-polarity summary
fields
q-bio.GN 1years
2026 1verdicts
UNVERDICTED 1roles
background 1polarities
background 1representative citing papers
citing papers explorer
-
Transcriptomic Models for Immunotherapy Response Prediction Show Limited Cross-cohort Generalisability
Systematic benchmarking shows existing transcriptomic predictors for immune checkpoint inhibitor response have limited cross-cohort generalisability and inconsistent biomarker signals.